
In regenerative dentistry, while graft performance is essential, safety is non-negotiable. Maxxeus Dental has defined the gold standard in allograft safety since 1990, utilizing the industry’s strictest processing protocols to deliver predictable clinical success.
Maxxeus biologics are processed in ISO Class 5 Clean Rooms using a patented bioburden reduction process. Every graft undergoes terminal sterilization to achieve a 10⁻⁶ Sterility Assurance Level (SAL), providing clinicians with the highest level of protection available for their patients.
Beyond safety, Maxxeus focuses on biological performance. Their range of DBM (Demineralized Bone Matrix) Putty and Crunch are verified for osteoinductivity, actively inducing new bone formation rather than simply acting as a space maintainer.
Maxxeus provides a complete ecosystem for hard and soft tissue regeneration. This includes Cortical/Cancellous blends for stable scaffolding and Acellular Dermal Matrix (ADM) for advanced periodontal soft tissue grafting.
In regenerative dentistry, Maxxeus Dental sets the global benchmark for allograft safety. Since 1990, their mission has been to provide biologics where safety is never an option, but a guarantee.
Every graft is processed in ISO Class 5 Clean Rooms and undergoes terminal sterilization to reach a 10⁻⁶ Sterility Level. This ensures absolute purity while maintaining the biological potential needed for rapid bone induction and predictable healing.